Moleculin Biotech Earnings History image   This MBRX earnings history page last updated 11/11/2024
Moleculin Biotech Earnings History Chart
PeriodEarnings DateGAAP
Q3 202411/8/2024-2.850
Q2 20248/14/2024-1.700
Q1 20245/10/2024-2.020
Q4 20233/22/2024-5.090
Q3 202311/13/2023-2.850
Q2 20238/11/2023-3.000
Q1 20235/11/2023-4.200
Q4 20223/22/2023-3.450
Q3 202211/10/2022-4.500
Q2 20228/15/2022-3.600
Q1 20225/12/2022-3.600
Q4 20213/24/2022-1.350
Q3 202111/10/2021-2.250
Q2 20218/11/2021-2.250
Q1 20215/12/2021-3.000
Q4 20203/24/2021-3.000
Q3 202011/12/2020-5.400
Q2 20208/12/2020-15.300
Q1 20205/11/2020-1.800
Q4 20193/19/2020-7.200
Q3 201911/12/2019-8.100
Q2 20198/16/2019-2.700
Q1 20195/14/2019-12.600
Q4 20182/21/2019-9.000
Q3 201811/13/2018-7.200
Q2 20188/10/2018-18.000
Q1 20185/15/2018-7.200
Q4 20173/28/2018-8.100
Q3 201711/13/2017-12.600
Q2 20178/14/2017-17.100
Q1 20175/15/2017-9.900
Q4 20164/3/2017-10.800
Q3 201611/21/2016-10.800
Q2 20168/15/2016-9.900
Moleculin Biotech Revenue History Chart
PeriodEarnings DateGAAP
Q3 202411/8/2024NA
Q2 20248/14/2024NA
Q1 20245/10/2024NA
Q4 20233/22/2024NA
Q3 202311/13/2023NA
Q2 20238/11/2023NA
Q1 20235/11/2023NA
Q4 20223/22/2023NA
Q3 202211/10/2022NA
Q2 20228/15/2022NA
Q1 20225/12/2022NA
Q4 20213/24/2022NA
Q3 202111/10/2021NA
Q2 20218/11/2021NA
Q1 20215/12/2021NA
Q4 20203/24/2021NA
Q3 202011/12/2020NA
Q2 20208/12/2020NA
Q1 20205/11/2020NA
Q4 20193/19/2020NA
Q3 201911/12/2019NA
Q2 20198/16/2019NA
Q1 20195/14/2019NA
Q4 20182/21/2019NA
Q3 201811/13/2018NA
Q2 20188/10/2018NA
Q1 20185/15/2018NA
Q4 20173/28/2018NA
Q3 201711/13/2017NA
Q2 20178/14/2017NA
Q1 20175/15/2017NA
Q4 20164/3/2017NA
Q3 201611/21/2016NA
Q2 20168/15/2016NA
Quotes delayed 20 minutes

Email EnvelopeFree MBRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options

Next Earnings Date Calendar:

Aramark (ARMK): 11/11/2024 6:33 AM
Strawberry Fields REIT (STRW): 11/11/2024 6:45 AM
Lincoln Educational Servs (LINC): 11/11/2024 8:00 AM
Luminar Technologies (LAZR): 11/11/2024 After close
Assertio Holdings (ASRT): 11/11/2024 After close
Intevac (IVAC): 11/11/2024 After close
Archrock (AROC): 11/11/2024 After close
Zeta Global Holdings (ZETA): 11/11/2024 After close
Beyond Air (XAIR): 11/11/2024 After close
Mineralys Therapeutics (MLYS): 11/11/2024 After close

More from the Next Earnings Dates Calendar

Earnings History:

RadNet (RDNT): 11/10/2024 After close
Moleculin Biotech (MBRX): 11/8/2024 5:10 PM
Associated Cap Gr (AC): 11/8/2024 After close
Tredegar (TG): 11/8/2024 After close
Global Self Storage (SELF): 11/8/2024 After close
Amcon Distributing (DIT): 11/8/2024 After close
Biglari Holdings (BH): 11/8/2024 After close
Hawaiian Electric Indus (HE): 11/8/2024 After close
FutureFuel (FF): 11/8/2024 After close
OptimumBank Hldgs (OPHC): 11/8/2024 11:30 AM

More from the Earnings History archive
Moleculin Biotech (MBRX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

MCK Past Earnings
MCRB Past Earnings
MD Past Earnings
MDGL Past Earnings
MDT Past Earnings
MDXG Past Earnings
ME Past Earnings
MEDP Past Earnings
MEIP Past Earnings
MGLN Past Earnings
On this page we presented the MBRX earnings and revenue history archive for Moleculin Biotech, comparing the historical top line revenue performance quarter by quarter, as well as the MBRX earnings per share history. Any self directed investor doing their due diligence on MBRX (or any other given stock) can benefit from researching all of the Moleculin Biotech past earnings and revenue results going backwards in time, and to help you with this Moleculin Biotech earnings history research, on this page we presented each quarter's resulting numbers in both table and graphical form for easy comparison. Studying these numbers can help an investor by providing important context with which to think about MBRX's next earnings report. In your continued research on Moleculin Biotech we hope you will be sure to check out the further links included for earnings surprises as well as next earnings dates for MBRX. Thanks for visiting, and the next time you need to research MBRX earnings history (or the earnings history of another stock), we hope you'll think of our site as your go-to earnings history research resource of choice.

Recommended: ETFs Holding DAN, YAC shares outstanding history, DCM Historical Stock Prices.

 

Moleculin Biotech Earnings History | www.NextEarningsDate.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in NextEarningsDate.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.